User profiles for Aiquan Chang
 | Aiquan ChangPhD Student, Weill Cornell Medicine - Cornell University Verified email at bwh.harvard.edu Cited by 1433 |
Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women
Importance Pregnant women are at increased risk of morbidity and mortality from COVID-19
but have been excluded from the phase 3 COVID-19 vaccine trials. Data on vaccine safety …
but have been excluded from the phase 3 COVID-19 vaccine trials. Data on vaccine safety …
[HTML][HTML] Immunogenicity of Ad26. COV2. S vaccine against SARS-CoV-2 variants in humans
The Ad26.COV2.S vaccine 1 , 2 – 3 has demonstrated clinical efficacy against symptomatic
COVID-19, including against the B.1.351 variant that is partially resistant to neutralizing …
COVID-19, including against the B.1.351 variant that is partially resistant to neutralizing …
[HTML][HTML] Durable humoral and cellular immune responses 8 months after Ad26. COV2. S vaccination
Durability of Response after Ad26.COV2.S Vaccination In this study, investigators measured
immune responses in 20 participants who had received either one or two doses of the Ad26.…
immune responses in 20 participants who had received either one or two doses of the Ad26.…
Intranasal vaccination with lipid-conjugated immunogens promotes antigen transmucosal uptake to drive mucosal and systemic immunity
To combat the HIV epidemic and emerging threats such as SARS-CoV-2, immunization
strategies are needed that elicit protection at mucosal portals of pathogen entry. Immunization …
strategies are needed that elicit protection at mucosal portals of pathogen entry. Immunization …
An aluminum hydroxide: CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice
Global deployment of vaccines that can provide protection across several age groups is still
urgently needed to end the COVID-19 pandemic, especially in low- and middle-income …
urgently needed to end the COVID-19 pandemic, especially in low- and middle-income …
SARS-CoV-2 receptor binding domain displayed on HBsAg virus–like particles elicits protective immunity in macaques
Authorized vaccines against SARS-CoV-2 remain less available in low- and middle-income
countries due to insufficient supply, high costs, and storage requirements. Global immunity …
countries due to insufficient supply, high costs, and storage requirements. Global immunity …
[HTML][HTML] Protective efficacy of Ad26. COV2. S against SARS-CoV-2 B. 1.351 in macaques
The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses
a threat to the efficacy of current COVID-19 vaccines 1 , 2 . The Ad26.COV2.S vaccine …
a threat to the efficacy of current COVID-19 vaccines 1 , 2 . The Ad26.COV2.S vaccine …
Immunity elicited by natural infection or Ad26. COV2. S vaccination protects hamsters against SARS-CoV-2 variants of concern
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern have
emerged and may pose a threat to both the efficacy of vaccines based on the original WA1/…
emerged and may pose a threat to both the efficacy of vaccines based on the original WA1/…
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice
Global containment of COVID-19 still requires accessible and affordable vaccines for low-
and middle-income countries (LMICs). Recently approved vaccines provide needed …
and middle-income countries (LMICs). Recently approved vaccines provide needed …
Correlates of neutralization against SARS-CoV-2 variants of concern by early pandemic sera
Emerging SARS-CoV-2 variants of concern that overcome natural and vaccine-induced
immunity threaten to exacerbate the COVID-19 pandemic. Increasing evidence suggests that …
immunity threaten to exacerbate the COVID-19 pandemic. Increasing evidence suggests that …